Literature DB >> 17438294

The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.

Thomas E Hall1, Robert J Bryson-Richardson, Silke Berger, Arie S Jacoby, Nicholas J Cole, Georgina E Hollway, Joachim Berger, Peter D Currie.   

Abstract

Mutations in the human laminin alpha2 (LAMA2) gene result in the most common form of congenital muscular dystrophy (MDC1A). There are currently three models for the molecular basis of cellular pathology in MDC1A: (i) lack of LAMA2 leads to sarcolemmal weakness and failure, followed by cellular necrosis, as is the case in Duchenne muscular dystrophy (DMD); (ii) loss of LAMA2-mediated signaling during the development and maintenance of muscle tissue results in myoblast proliferation and fusion defects; (iii) loss of LAMA2 from the basement membrane of the Schwann cells surrounding the peripheral nerves results in a lack of motor stimulation, leading to effective denervation atrophy. Here we show that the degenerative muscle phenotype in the zebrafish dystrophic mutant, candyfloss (caf) results from mutations in the laminin alpha2 (lama2) gene. In vivo time-lapse analysis of mechanically loaded fibers and membrane permeability assays suggest that, unlike DMD, fiber detachment is not initially associated with sarcolemmal rupture. Early muscle formation and myoblast fusion are normal, indicating that any deficiency in early Lama2 signaling does not lead to muscle pathology. In addition, innervation by the primary motor neurons is unaffected, and fiber detachment stems from muscle contraction, demonstrating that muscle atrophy through lack of motor neuron activity does not contribute to pathology in this system. Using these and other analyses, we present a model of lama2 function where fiber detachment external to the sarcolemma is mechanically induced, and retracted fibers with uncompromised membranes undergo subsequent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438294      PMCID: PMC1855385          DOI: 10.1073/pnas.0700942104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Laminins: structure and genetic regulation.

Authors:  P Tunggal; N Smyth; M Paulsson; M C Ott
Journal:  Microsc Res Tech       Date:  2000-11-01       Impact factor: 2.769

2.  Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).

Authors:  Valérie Allamand; Pascale Guicheney
Journal:  Eur J Hum Genet       Date:  2002-02       Impact factor: 4.246

3.  Essential and overlapping roles for laminin alpha chains in notochord and blood vessel formation.

Authors:  Steven M Pollard; Michael J Parsons; Makoto Kamei; Ross N W Kettleborough; Kevin A Thomas; Van N Pham; Moon-Kyoung Bae; Annabelle Scott; Brant M Weinstein; Derek L Stemple
Journal:  Dev Biol       Date:  2006-01-01       Impact factor: 3.582

4.  A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice.

Authors:  John D Porter; Sangeeta Khanna; Henry J Kaminski; J Sunil Rao; Anita P Merriam; Chelliah R Richmonds; Patrick Leahy; Jingjin Li; Wei Guo; Francisco H Andrade
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

5.  Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during development.

Authors:  Toshihiro Masaki; Kiichiro Matsumura; Akira Hirata; Hiroki Yamada; Asako Hase; Ken Arai; Teruo Shimizu; Hiroshi Yorifuji; Kazuo Motoyoshi; Keiko Kamakura
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

Review 6.  Molecular basis of muscular dystrophies.

Authors:  R D Cohn; K P Campbell
Journal:  Muscle Nerve       Date:  2000-10       Impact factor: 3.217

7.  Merosin-integrin promotion of skeletal myofiber cell survival: Differentiation state-distinct involvement of p60Fyn tyrosine kinase and p38alpha stress-activated MAP kinase.

Authors:  Patrick Laprise; Eve-Marie Poirier; Anne Vézina; Nathalie Rivard; Pierre H Vachon
Journal:  J Cell Physiol       Date:  2002-04       Impact factor: 6.384

Review 8.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

9.  A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy.

Authors:  E Pegoraro; M Fanin; C P Trevisan; C Angelini; E P Hoffman
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

10.  Zebrafish mutants identify an essential role for laminins in notochord formation.

Authors:  Michael J Parsons; Steven M Pollard; Leonor Saúde; Benjamin Feldman; Pedro Coutinho; Elizabeth M A Hirst; Derek L Stemple
Journal:  Development       Date:  2002-07       Impact factor: 6.868

View more
  84 in total

Review 1.  Congenital muscular dystrophies: toward molecular therapeutic interventions.

Authors:  James Collins; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

2.  The development of the myotendinous junction. A review.

Authors:  Benjamin Charvet; Florence Ruggiero; Dominique Le Guellec
Journal:  Muscles Ligaments Tendons J       Date:  2012-09-10

Review 3.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

4.  Triggering Cell Stress and Death Using Conventional UV Laser Confocal Microscopy.

Authors:  Marco Morsch; Rowan A W Radford; Emily K Don; Albert Lee; Elinor Hortle; Nicholas J Cole; Roger S Chung
Journal:  J Vis Exp       Date:  2017-02-03       Impact factor: 1.355

Review 5.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

6.  The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment.

Authors:  Arie S Jacoby; Elisabeth Busch-Nentwich; Robert J Bryson-Richardson; Thomas E Hall; Joachim Berger; Silke Berger; Carmen Sonntag; Caroline Sachs; Robert Geisler; Derek L Stemple; Peter D Currie
Journal:  Development       Date:  2009-10       Impact factor: 6.868

Review 7.  The extracellular matrix in development and morphogenesis: a dynamic view.

Authors:  Tania Rozario; Douglas W DeSimone
Journal:  Dev Biol       Date:  2009-10-23       Impact factor: 3.582

8.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

Review 9.  The role of laminins in cartilaginous tissues: from development to regeneration.

Authors:  Y Sun; T L Wang; W S Toh; M Pei
Journal:  Eur Cell Mater       Date:  2017-07-21       Impact factor: 3.942

Review 10.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.